CN104450606B - Sweat gland cells inducing culture and its application - Google Patents
Sweat gland cells inducing culture and its application Download PDFInfo
- Publication number
- CN104450606B CN104450606B CN201410786562.3A CN201410786562A CN104450606B CN 104450606 B CN104450606 B CN 104450606B CN 201410786562 A CN201410786562 A CN 201410786562A CN 104450606 B CN104450606 B CN 104450606B
- Authority
- CN
- China
- Prior art keywords
- sweat gland
- cells
- sweat
- stem cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000106 sweat gland Anatomy 0.000 title claims abstract description 119
- 230000001939 inductive effect Effects 0.000 title claims description 17
- 210000004027 cell Anatomy 0.000 claims abstract description 147
- 210000000130 stem cell Anatomy 0.000 claims abstract description 56
- 230000004069 differentiation Effects 0.000 claims abstract description 24
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 14
- 102000008137 Bone Morphogenetic Protein 4 Human genes 0.000 claims abstract description 9
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims abstract description 9
- 229930182555 Penicillin Natural products 0.000 claims abstract description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 9
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 210000002510 keratinocyte Anatomy 0.000 claims abstract description 9
- 229940049954 penicillin Drugs 0.000 claims abstract description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 8
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 7
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 7
- 239000011781 sodium selenite Substances 0.000 claims abstract description 7
- 210000004381 amniotic fluid Anatomy 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 4
- 210000004243 sweat Anatomy 0.000 abstract description 60
- 239000002609 medium Substances 0.000 abstract description 39
- 230000006698 induction Effects 0.000 abstract description 35
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract description 12
- 239000006143 cell culture medium Substances 0.000 abstract description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract description 7
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 abstract description 7
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract description 7
- 229930182816 L-glutamine Natural products 0.000 abstract description 7
- 239000012091 fetal bovine serum Substances 0.000 abstract description 7
- 229960005322 streptomycin Drugs 0.000 abstract description 6
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract description 5
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract description 5
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract description 3
- 101800003838 Epidermal growth factor Proteins 0.000 abstract description 3
- 206010053615 Thermal burn Diseases 0.000 abstract description 3
- 229940116977 epidermal growth factor Drugs 0.000 abstract description 3
- 229940035722 triiodothyronine Drugs 0.000 abstract description 3
- 102100021866 Hepatocyte growth factor Human genes 0.000 abstract 1
- 229960002743 glutamine Drugs 0.000 abstract 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 25
- 238000010586 diagram Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 6
- 101000920026 Homo sapiens Tumor necrosis factor receptor superfamily member EDAR Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 102100030810 Tumor necrosis factor receptor superfamily member EDAR Human genes 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 210000000110 microvilli Anatomy 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 210000003463 organelle Anatomy 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 230000003248 secreting effect Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000002557 hidradenitis Diseases 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002993 trophoblast Anatomy 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Substances OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种汗腺细胞诱导培养基及其应用,所述汗腺细胞诱导培养基包括DMEM/F12细胞培养基、角质化细胞培养基、胎牛血清、表皮生长因子、三碘甲状腺原氨酸、氢化可的松、胰岛素‑转铁蛋白‑亚硒酸钠、L‑谷氨酰胺、青霉素、链霉素、肝细胞生长因子以及骨形态发生蛋白4。采用本发明的汗腺细胞诱导培养基可以成功诱导干细胞定向分化为汗腺样细胞,为大面积烧伤病人的救治提供足够数量的汗腺细胞,大大改善病人的生活质量。也为研究汗腺的分化发育提供的理论依据,具有潜在的临床应用前景。
The invention discloses a sweat gland cell induction medium and its application. The sweat gland cell induction medium comprises DMEM/F12 cell culture medium, keratinocyte culture medium, fetal bovine serum, epidermal growth factor and triiodothyronine , hydrocortisone, insulin-transferrin-sodium selenite, L-glutamine, penicillin, streptomycin, hepatocyte growth factor, and bone morphogenetic protein 4. The sweat gland cell induction medium of the present invention can successfully induce stem cells to differentiate into sweat gland-like cells, provide sufficient sweat gland cells for the treatment of patients with extensive burns, and greatly improve the patient's quality of life. It also provides a theoretical basis for studying the differentiation and development of sweat glands, and has potential clinical application prospects.
Description
技术领域technical field
本发明涉及一种汗腺细胞诱导培养基及其在诱导干细胞分化为汗腺样细胞中的应用,属于汗腺细胞培养技术领域。The invention relates to a sweat gland cell induction medium and its application in inducing stem cells to differentiate into sweat gland-like cells, belonging to the technical field of sweat gland cell culture.
背景技术Background technique
我国烧伤年发病率约为1.5%~2%,即每年约有千万人遭受不同程度烧伤,近万人严重烧伤,其中约10%病人由于缺乏皮源无法挽救其性命。大面积烧伤获救病人由于无功能的疤痕组织取代皮肤使其终生丧失正常皮肤功能,严重影响病人生活质量。大面积皮肤严重烧伤的救治是目前亟待解决的医学和社会问题。The annual incidence of burns in my country is about 1.5% to 2%, that is, about 10 million people suffer from different degrees of burns every year, and nearly 10,000 people suffer from severe burns, and about 10% of the patients cannot save their lives due to lack of skin sources. The rescued patients with extensive burns lost their normal skin function for life due to non-functional scar tissue replacing the skin, which seriously affected the quality of life of the patients. The treatment of severe burns on large areas of skin is a medical and social problem to be solved urgently.
皮肤是人体最大的器官,具有保护身体,排汗,感觉冷热和压力等功能。其中汗腺作为重要的功能性皮肤附属器,在调节体温,分泌汗液及排出人体部分代谢产物的过程中发挥着重要的作用。人体中汗腺分为两种,顶泌汗腺和外泌汗腺。顶泌汗腺较大,有较大的官腔,与体温调节无关。外泌汗腺较小,分布于人体全身,参与体温调节。The skin is the largest organ in the human body and has functions such as protecting the body, perspiration, and sensing heat, cold, and pressure. Among them, sweat glands, as important functional skin appendages, play an important role in the process of regulating body temperature, secreting sweat and excreting some metabolites of the human body. There are two types of sweat glands in the human body, apocrine sweat glands and eccrine sweat glands. Apocrine sweat glands are larger, have larger cavities, and are not involved in thermoregulation. Eccrine sweat glands are small, distributed throughout the body and involved in temperature regulation.
外泌汗腺分为导管部和分泌部。分泌部位于真皮层或皮下组织内,是卷曲的小管,而导管部开口于表皮层,连接分泌部和外界环境。Eccrine sweat glands are divided into ductal and secretory parts. The secretory part is located in the dermis or subcutaneous tissue and is a coiled tubule, while the ductal part opens in the epidermis and connects the secretory part with the external environment.
轻度烧伤,汗腺的导管细胞可以其深部未受创部分为模版,通过干细胞的分化形成它特有的三维结构而完全修复。但是,全层皮肤大面积深度烧伤,汗腺则不能依赖干细胞的分裂增殖与终末分化来自我更新而重建其复杂结构。For mild burns, the ductal cells of the sweat glands can be completely repaired by using the deep uninjured part as a template to form its unique three-dimensional structure through the differentiation of stem cells. However, in the case of deep burns on a large area of full-thickness skin, sweat glands cannot rely on the division, proliferation and terminal differentiation of stem cells to self-renew and rebuild their complex structures.
人体内存在的汗腺数量是一定的,由于其发育是一个复杂的过程,一旦大面积受损,将无法快速有效的恢复有功能性的汗腺。故创面虽经覆盖,但无排汗功能,严重影响病人生活质量。The number of sweat glands in the human body is certain. Since its development is a complicated process, once a large area is damaged, it will not be possible to quickly and effectively restore functional sweat glands. Therefore, although the wound surface is covered, it has no perspiration function, which seriously affects the patient's quality of life.
皮肤组织修复和功能重建在国内和国际上都是生物医学领域研究的核心和热点。目前,汗腺组织的发育机制还不明确,无法实现临床大量移植。研究表明,干细胞可以定向分化为并构建具有覆盖保护能力的表皮层组织;然而对于真皮层组织中的功能性皮肤附属器,目前干细胞汗腺细胞定向分化尚未见报道。Skin tissue repair and functional reconstruction are the core and hotspots of biomedical research both domestically and internationally. At present, the development mechanism of sweat gland tissue is still unclear, and it is impossible to achieve clinical mass transplantation. Studies have shown that stem cells can be directed to differentiate into and construct epidermis tissue with the ability to cover and protect; however, for functional skin appendages in dermis tissue, the directed differentiation of stem cells and sweat gland cells has not been reported so far.
利用胶原酶消化皮肤,待汗腺个体游离出来在倒置显微镜下吸取分离出至培养皿中培养可以形成汗腺细胞。但目前对此研究存在一些问题,如汗腺分离纯化困难且在体外培养传代有限,限制其应用;同时,体外培养汗腺所用的培养基目前还没有确定,对于汗腺细胞体外培养效果均不理想。The skin is digested with collagenase, and the individual sweat glands are freed, sucked and separated under an inverted microscope, and cultured in a petri dish to form sweat gland cells. However, there are some problems in this research at present, such as the difficulty in the separation and purification of sweat glands and the limited passage in vitro culture, which limits its application; at the same time, the medium used for culturing sweat glands in vitro has not yet been determined, and the effect of culturing sweat gland cells in vitro is not ideal.
现有研究发现,与汗腺细胞共培养的干细胞可分化为汗腺细胞。将汗腺细胞进行热休克处理,收集热休克后汗腺细胞的培养上清,与间充质干细胞共培养,发现间充质干细胞可以分化成具有汗腺表型的细胞。但是这一方法也存在问题,由于汗腺细胞分离纯化和传代培养效率低,获取大量培养上清存在困难;而且培养上清成分不清楚,其具体作用机制也不明;特别是能否获得具有功能性的汗腺细胞还不确定。Existing studies have found that stem cells co-cultured with sweat gland cells can differentiate into sweat gland cells. Sweat gland cells were subjected to heat shock treatment, and the culture supernatant of sweat gland cells after heat shock was collected and co-cultured with mesenchymal stem cells. It was found that mesenchymal stem cells could differentiate into cells with sweat gland phenotype. However, this method also has problems. Due to the low efficiency of sweat gland cell separation, purification and subculture, it is difficult to obtain a large amount of culture supernatant; and the composition of the culture supernatant is not clear, and its specific mechanism of action is also unclear; The sweat gland cells are not yet identified.
因此研发新的诱导分化培养基,建立新型高效的干细胞汗腺细胞定向分化方法十分必要。Therefore, it is necessary to develop a new induction differentiation medium and establish a new and efficient method for the directed differentiation of stem cells and sweat gland cells.
发明内容Contents of the invention
本发明的目的是提供一种可以将干细胞定向诱导分化为汗腺样细胞的诱导分化培养基;并公开了利用其将干细胞诱导分化为汗腺样细胞的方法,从而解决大面积烧伤病人救治过程中对汗腺的需求。The purpose of the present invention is to provide a kind of induction differentiation medium that can directionally induce and differentiate stem cells into sweat gland-like cells; and disclose a method for using it to induce the differentiation of stem cells into sweat gland-like cells, thereby solving the problem in the treatment of patients with large area burns The needs of the sweat glands.
为达到上述发明目的,本发明采用的技术方案是:一种汗腺细胞诱导培养基,所述汗腺细胞诱导培养基包括体积比为(0.8~1)∶1的DMEM/F12细胞培养基和角质化细胞培养基;还包括以下成分,各成分的用量为:In order to achieve the purpose of the above invention, the technical scheme adopted in the present invention is: a sweat gland cell induction medium, which includes DMEM/F12 cell culture medium and keratinized Cell culture medium; also includes the following ingredients in amounts of:
胎牛血清 3~6%Fetal bovine serum 3~6%
表皮生长因子 40~55μg/LEpidermal growth factor 40~55μg/L
三碘甲状腺原氨酸 0.5~1.5mmol/LTriiodothyronine 0.5~1.5mmol/L
氢化可的松 0.1~0.3mg/LHydrocortisone 0.1~0.3mg/L
胰岛素-转铁蛋白-亚硒酸钠 0.5~2%Insulin-transferrin-sodium selenite 0.5~2%
L-谷氨酰胺 0.5~2mmol/LL-Glutamine 0.5~2mmol/L
青霉素 0.02~0.08U/LPenicillin 0.02~0.08U/L
链霉素 0.02~0.09μg/LStreptomycin 0.02~0.09μg/L
肝细胞生长因子 20~30μg/LHepatocyte growth factor 20~30μg/L
骨形态发生蛋白4 8~12μg/L。Bone morphogenetic protein 4 8~12μg/L.
优选的,所述汗腺细胞诱导培养基包括体积比为0.9∶1的DMEM/F12细胞培养基和角质化细胞培养基;还包括以下成分,各成分的用量为:Preferably, the sweat gland cell induction medium includes DMEM/F12 cell culture medium and keratinocyte culture medium with a volume ratio of 0.9:1; it also includes the following components, and the consumption of each component is:
胎牛血清 5%Fetal bovine serum 5%
表皮生长因子 50μg/LEpidermal Growth Factor 50μg/L
三碘甲状腺原氨酸 1mmol/LTriiodothyronine 1mmol/L
氢化可的松 0.2mg/LHydrocortisone 0.2mg/L
胰岛素-转铁蛋白-亚硒酸钠 1%Insulin-Transferrin-Sodium Selenite 1%
L-谷氨酰胺 1mmol/LL-Glutamine 1mmol/L
青霉素 0.05U/LPenicillin 0.05U/L
链霉素 0.05μg/LStreptomycin 0.05μg/L
肝细胞生长因子 25μg/LHepatocyte Growth Factor 25μg/L
骨形态发生蛋白4 10μg/L。Bone morphogenetic protein 4 10 μg/L.
上述技术方案中,所述角质化细胞培养基为KGM2细胞培养基。In the above technical scheme, the keratinocyte culture medium is KGM2 cell culture medium.
本发明还公开了上述汗腺细胞诱导培养基在诱导干细胞分化为汗腺样细胞中的应用。The invention also discloses the application of the sweat gland cell induction medium in inducing stem cells to differentiate into sweat gland-like cells.
上述技术方案中,所述干细胞为羊水干细胞或者多潜能干细胞。In the above technical solution, the stem cells are amniotic fluid stem cells or pluripotent stem cells.
利用上述汗腺细胞诱导培养基诱导干细胞分化为汗腺样细胞的方法,包括取干细胞铺于培养皿中,贴壁培养;待所述干细胞贴壁后,添加汗腺细胞诱导培养基,开始诱导干细胞;然后每天更换汗腺细胞诱导培养基;待诱导后的干细胞生长至汇合率为70~80%,进行消化传代,按1传3的比例接种至新的培养皿中,添加汗腺定向诱导分化培养基;诱导分化一段时间后得到汗腺样细胞,并对其进行汗腺指标的检测。干细胞的数量与培养器具有关,如果太多细胞的生长会太快导致消化传代的次数会增多,比如取1×105干细胞种在6孔板里,密度比较合适。The method for inducing stem cells to differentiate into sweat gland-like cells using the above-mentioned sweat gland cell induction medium, comprising taking stem cells and laying them on a culture dish, and culturing them on the wall; after the stem cells are attached to the wall, adding sweat gland cell induction medium to start inducing the stem cells; Change the sweat gland cell induction medium every day; the stem cells to be induced grow to a confluence rate of 70-80%, digest and passage, inoculate into a new culture dish at a ratio of 1 pass to 3, add sweat gland directional induction differentiation medium; induce After a period of differentiation, sweat gland-like cells were obtained, and sweat gland indicators were detected on them. The number of stem cells is related to the culture equipment. If too many cells grow too fast, the number of digestion passages will increase. For example, 1×10 5 stem cells are planted in a 6-well plate, and the density is more appropriate.
本发明中,羊水干细胞(Amniotic Fluid Stem Cell, AFS)具有良好的增殖效率以及低免疫源性,是一种新型的干细胞。In the present invention, amniotic fluid stem cells (Amniotic Fluid Stem Cell, AFS) have good proliferation efficiency and low immunogenicity, and are a new type of stem cells.
由于上述技术方案运用,本发明与现有技术相比具有下列优点:Owing to above-mentioned technical scheme uses, the present invention has following advantage compared with prior art:
1.本发明公开了一种新的汗腺诱导培养基,能有效的诱导干细胞分化为汗腺样细胞;运用本发明的汗腺诱导培养基可很好地将干细胞在体外诱导分化为具有汗腺细胞表型的汗腺样细胞,并且该汗腺样细胞在胶中可形成类似于汗腺结构的管状结构。1. The invention discloses a new sweat gland induction medium, which can effectively induce stem cells to differentiate into sweat gland-like cells; using the sweat gland induction medium of the invention can well induce and differentiate stem cells into sweat glands with sweat gland cell phenotype in vitro Like cells, and the sweat gland-like cells can form a tubular structure similar to the structure of sweat glands in the gel.
2.本发明以DMEM/F12细胞培养基和角质化细胞培养基为基础培养基配置新的汗腺诱导培养基,用于诱导干细胞转化为汗腺细胞时的培养设备简单,操作步骤简便、快速,成本低,适用于大量干细胞的诱导分化,易于推广普及。2. The present invention uses DMEM/F12 cell culture medium and keratinocyte culture medium as the base medium to configure a new sweat gland induction medium, and the culture equipment for inducing stem cells to transform into sweat gland cells is simple, the operation steps are simple and fast, and the cost is low. It is suitable for inducing differentiation of a large number of stem cells and is easy to popularize.
附图说明Description of drawings
图1为实施例一中人羊水干细胞、诱导后的汗腺样细胞、人汗腺细胞的形态图;Figure 1 is a morphological diagram of human amniotic fluid stem cells, induced sweat gland-like cells, and human sweat gland cells in Example 1;
图2为实施例一中mRNA水平上检测诱导得到的汗腺样细胞的汗腺指标图;Fig. 2 is the sweat gland indicator diagram of the sweat gland-like cells induced by detection at the mRNA level in Example 1;
图3为实施例一中诱导得到的汗腺样细胞的分化比率图;Figure 3 is a diagram of the differentiation ratio of sweat gland-like cells induced in Example 1;
图4为实施例一中人羊水干细胞、诱导后的汗腺样细胞、人汗腺细胞的透射电镜图;4 is a transmission electron microscope image of human amniotic fluid stem cells, induced sweat gland-like cells, and human sweat gland cells in Example 1;
图5为实施例一中人汗腺组织、诱导后的汗腺样细胞、人汗腺细胞的汗腺样导管结构图;5 is a structural diagram of human sweat gland tissue, induced sweat gland-like cells, and sweat gland-like ducts of human sweat gland cells in Example 1;
图6 为实施例一中人羊水干细胞经诱导后得到的汗腺样细胞在胶中形成管腔的过程图;Fig. 6 is a diagram of the process of forming a lumen in the gel of the sweat gland-like cells obtained after the induction of human amniotic fluid stem cells in Example 1;
图7为实施例二中多潜能干细胞、诱导后的汗腺样细胞、人汗腺细胞的形态图;7 is a morphological diagram of pluripotent stem cells, induced sweat gland-like cells, and human sweat gland cells in Example 2;
图8为实施例二中mRNA水平上检测诱导得到的汗腺样细胞的汗腺指标图;Fig. 8 is a sweat gland index diagram of the sweat gland-like cells induced by detection at the mRNA level in Example 2;
图9为实施例二中诱导得到的汗腺样细胞的分化比率图;Figure 9 is a diagram of the differentiation ratio of sweat gland-like cells induced in Example 2;
图10为实施例二中多潜能干细胞、诱导后的汗腺样细胞、人汗腺细胞的透射电镜图;10 is a transmission electron microscope image of pluripotent stem cells, induced sweat gland-like cells, and human sweat gland cells in Example 2;
图11为实施例二中人汗腺组织、诱导后的汗腺样细胞、人汗腺细胞的汗腺样导管结构图;Figure 11 is a structural diagram of human sweat gland tissue, induced sweat gland-like cells, and sweat gland-like ducts of human sweat gland cells in Example 2;
图12 为实施例二中多潜能干细胞经诱导后得到的汗腺样细胞在胶中形成管腔的过程图。FIG. 12 is a diagram of the process of forming a lumen in the gel of the sweat gland-like cells obtained from the induced pluripotent stem cells in Example 2. FIG.
具体实施方式detailed description
下面结合实施例与附图对本发明作进一步描述:Below in conjunction with embodiment and accompanying drawing, the present invention will be further described:
实施例一:诱导人羊水干细胞分化为汗腺样细胞Example 1: Inducing human amniotic fluid stem cells to differentiate into sweat gland-like cells
汗腺细胞诱导培养基,包括450mL DMEM/F12细胞培养基(Hyclone,SH30023.01B),500mL角质化细胞培养基(KGM2)(Lonza,CC-3107),额外添加50mL特级胎牛血清、1mmol/L三碘甲状腺原氨酸、0.2mg/L氢化可的松、1%胰岛素-转铁蛋白-亚硒酸钠、1mmol/L L-谷氨酰胺、0.05U/L青霉素和0.05μg/L链霉素;再加入50μg/L表皮生长因子(EGF),25μg/L肝细胞生长因子(HGF)以及10μg/L骨形态发生蛋白4(BMP4)。Sweat gland cell induction medium, including 450mL DMEM/F12 cell culture medium (Hyclone, SH30023.01B), 500mL keratinocyte medium (KGM2) (Lonza, CC-3107), additionally add 50mL special grade fetal bovine serum, 1mmol/L Triiodothyronine, 0.2 mg/L hydrocortisone, 1% insulin-transferrin-sodium selenite, 1 mmol/L L-glutamine, 0.05 U/L penicillin and 0.05 μg/L streptavidin Add 50 μg/L epidermal growth factor (EGF), 25 μg/L hepatocyte growth factor (HGF) and 10 μg/L bone morphogenetic protein 4 (BMP4).
诱导羊水干细胞分化为汗腺样细胞,包括以下步骤:Inducing amniotic fluid stem cells to differentiate into sweat gland-like cells, including the following steps:
(1)取5×104个/孔的人羊水干细胞铺于6孔板中,使用羊水干细胞培养基培养;(1) Take 5 ×104 cells/well of human amniotic fluid stem cells and spread them in a 6-well plate, and culture them with amniotic fluid stem cell medium;
羊水干细胞培养基:α-MEM培养基中添加 15%胎牛血清(FBS),1 mM L-谷氨酰胺和0.05U/L青霉素,0.05μg/L链霉素,18%Chang B 和2%Chang C 培养基;Amniotic fluid stem cell medium: α-MEM medium supplemented with 15% fetal bovine serum (FBS), 1 mM L-glutamine and 0.05U/L penicillin, 0.05μg/L streptomycin, 18% Chang B and 2% Chang C medium;
(2)20h后,待羊水干细胞贴壁后,添加汗腺细胞诱导培养基;然后每天更换培养汗腺细胞诱导培养基;(2) After 20 hours, after the amniotic fluid stem cells adhere to the wall, add sweat gland cell induction medium; then change the culture sweat gland cell induction medium every day;
(3)待诱导后的羊水干细胞生长至汇合率为80%,吸去培养基,用磷酸盐缓冲液(PBS)清洗,使用1mL 0.25%胰酶对细胞消化2分钟,使用含血清的培养基终止胰酶的作用,将消化下来的细胞吸入离心管中离心,1200转/分钟,离心5分钟。弃去上清,加入汗腺细胞诱导培养基,将细胞沉淀混匀,按1传3的比例接种细胞至新的培养皿中;(3) After the induced amniotic fluid stem cells were grown to a confluence rate of 80%, the culture medium was aspirated, washed with phosphate buffered saline (PBS), and cells were digested with 1 mL of 0.25% trypsin for 2 minutes, and the culture medium containing serum was used Terminate the action of trypsin, suck the digested cells into a centrifuge tube and centrifuge at 1200 rpm for 5 minutes. Discard the supernatant, add sweat gland cell induction medium, mix the cell pellet, and inoculate the cells into a new culture dish at a ratio of 1 to 3;
(4)重复步骤(3),诱导分化28天后得到汗腺样细胞,并对其进行汗腺指标的检测。(4) Repeat step (3) to obtain sweat gland-like cells after 28 days of induced differentiation, and detect sweat gland indicators on them.
附图1为体外培养的人羊水干细胞,人羊水干细胞诱导分化的汗腺样细胞以及人汗腺细胞在光学显微镜下的形态图。可以看出人羊水干细胞,细胞较小,呈梭型,排列无规则;由人羊水干细胞诱导分化得到的汗腺样细胞,细胞变大,成上皮细胞样,排列规则;人汗腺细胞,细胞较大,具有明显的上皮细胞形态,呈铺路石状生长,细胞排列整齐。人羊水干细胞经过汗腺诱导培养基诱导分化后得到的汗腺样细胞在形态上接近体外培养的人汗腺细胞。Accompanying drawing 1 is the morphological diagram of human amniotic fluid stem cells cultured in vitro, sweat gland-like cells induced and differentiated from human amniotic fluid stem cells, and human sweat gland cells under an optical microscope. It can be seen that human amniotic fluid stem cells are small, spindle-shaped, and arranged irregularly; sweat gland-like cells induced and differentiated from human amniotic fluid stem cells are enlarged, epithelial-like, and arranged regularly; human sweat gland cells are larger , with a distinct epithelial cell morphology, showing paving stone-like growth with neatly arranged cells. The sweat gland-like cells obtained after the differentiation of human amniotic fluid stem cells by sweat gland induction medium are similar in morphology to human sweat gland cells cultured in vitro.
附图2为mRNA水平上检测诱导得到的汗腺样细胞的汗腺指标图。Realtime-PCR 结果显示,人羊水干细胞在诱导的过程中,逐渐表达汗腺细胞指标EDA、EDAR、K8 和CEA,且在分化的过程中逐渐接近汗腺细胞。人羊水干细胞(hAFS)作为阴性对照,人汗腺细胞(hSG)作为阳性对照。Accompanying drawing 2 is the sweat gland indicator map of the induced sweat gland-like cells detected at the mRNA level. Realtime-PCR results showed that human amniotic fluid stem cells gradually expressed sweat gland cell indicators EDA, EDAR, K8 and CEA during the induction process, and gradually approached sweat gland cells during the differentiation process. Human amniotic fluid stem cells (hAFS) were used as a negative control, and human sweat gland cells (hSG) were used as a positive control.
附图3为诱导得到的汗腺样细胞的分化比率图。经过28天的诱导,用流式细胞仪技术检测诱导后的细胞在汗腺细胞指标上的表达。经过分析,人羊水干细胞诱导后的汗腺样细胞表达EDA大约36%,EDAR大约43%, K8大约45%,CEA大约32%。人羊水干细胞可以很好的被诱导分化为汗腺养细胞。Accompanying drawing 3 is the graph of the differentiation ratio of the induced sweat gland-like cells. After 28 days of induction, the expression of the induced cells on sweat gland cell indicators was detected by flow cytometry. After analysis, the sweat gland-like cells induced by human amniotic fluid stem cells expressed about 36% of EDA, about 43% of EDAR, about 45% of K8, and about 32% of CEA. Human amniotic fluid stem cells can be well induced to differentiate into sweat gland trophoblasts.
附图4为透射电镜在细胞器水平上检测人羊水干细胞,人羊水干细胞诱导分化的汗腺样细胞以及人汗腺细胞的汗腺指标图。人羊水干细胞诱导后得到的汗腺样细胞在细胞器水平上接近人汗腺细胞,具体表现在诱导后的汗腺样细胞具有人汗腺细胞有的微绒毛(黑色箭头),而人羊水干细胞则没有微绒毛。Accompanying drawing 4 is the human amniotic fluid stem cell detected at the organelle level by the transmission electron microscope, the sweat gland-like cells induced and differentiated by the human amniotic fluid stem cell, and the sweat gland index diagram of the human sweat gland cell. The sweat gland-like cells induced by human amniotic fluid stem cells are close to human sweat gland cells at the organelle level. Specifically, the induced sweat gland-like cells have microvilli (black arrows) that human sweat gland cells have, while human amniotic fluid stem cells do not have microvilli.
附图5为人汗腺组织,人羊水干细胞诱导分化的汗腺样细胞以及人汗腺细胞的汗腺样导管结构图,图中可见汗腺管状结构的横截面,能观察到汗腺管腔;人羊水干细胞诱导后得到的汗腺样细胞在胶中形成的汗腺管状结构,可见管状结构横截面以及管腔;人汗腺细胞在胶中形成的管状结构,可见管状结构横截面以及管腔。Accompanying drawing 5 is the human sweat gland tissue, the sweat gland-like cell induced differentiation of human amniotic fluid stem cell and the sweat gland-like duct structure diagram of human sweat gland cell, the cross-section of the sweat gland tubular structure can be seen in the figure, and the sweat gland lumen can be observed; The sweat gland tubular structure formed by human sweat gland-like cells in the gel, the tubular structure cross-section and lumen can be seen; the tubular structure formed by human sweat gland cells in the glue, the tubular structure cross-section and lumen can be seen.
附图6 为人羊水干细胞经诱导后得到的汗腺样细胞在胶中形成管腔的过程。汗腺样细胞在胶中增殖成团,中间的细胞逐渐凋亡,形成管腔。Accompanying drawing 6 is the process of forming tube lumens of sweat gland-like cells obtained after human amniotic fluid stem cells are induced. Sweat gland-like cells proliferated into clusters in the gel, and the cells in the middle gradually apoptotic to form a lumen.
实施例二:诱导多潜能干细胞分化为汗腺样细胞Example 2: Inducing Pluripotent Stem Cells to Differentiate into Sweat Gland-like Cells
汗腺细胞诱导培养基,包括450mLDMEM/F12细胞培养基、450mL角质化细胞培养基(KGM2),额外添加55mL特级胎牛血清、1.5mmol/L三碘甲状腺原氨酸、0.3mg/L氢化可的松、2%胰岛素-转铁蛋白-亚硒酸钠、1.5mmol/L L-谷氨酰胺、0.08U/L青霉素和0.09μg/L链霉素;再加入55μg/L表皮生长因子(EGF),30μg/L肝细胞生长因子(HGF)以及8μg/L骨形态发生蛋白4(BMP4)。Sweat gland cell induction medium, including 450mL DMEM/F12 cell culture medium, 450mL keratinocyte medium (KGM2), additionally added 55mL special grade fetal bovine serum, 1.5mmol/L triiodothyronine, 0.3mg/L hydrocortisone Pine, 2% insulin-transferrin-sodium selenite, 1.5mmol/L L-glutamine, 0.08U/L penicillin and 0.09μg/L streptomycin; then add 55μg/L epidermal growth factor (EGF) , 30 μg/L hepatocyte growth factor (HGF) and 8 μg/L bone morphogenetic protein 4 (BMP4).
诱导多潜能干细胞分化为汗腺样细胞,包括以下步骤:Inducing pluripotent stem cells to differentiate into sweat gland-like cells includes the following steps:
(1)取1×105个/孔的多潜能干细胞铺于6孔板中,使用多潜能干细胞培养基培养;(1) Spread 1×10 5 pluripotent stem cells/well in a 6-well plate and culture in pluripotent stem cell medium;
多潜能干细胞培养基:含20%KnockOut血清、1%非必需氨基酸、0.1mmol/Lβ-2-巯基乙醇、4μg/L FGF-based、2mmol/L L-谷氨酰胺、0.1U/L 青霉素和 0.1ug/L链霉素的 DMEDF12 细胞培养基。Pluripotent stem cell medium: containing 20% KnockOut serum, 1% non-essential amino acids, 0.1mmol/L β-2-mercaptoethanol, 4μg/L FGF-based, 2mmol/L L-glutamine, 0.1U/L penicillin and DMEDF12 cell culture medium with 0.1ug/L streptomycin.
(2)24h后,待多潜能干细胞贴壁后,添加汗腺细胞诱导培养基;然后每天更换培养汗腺细胞诱导培养基;(2) After 24 hours, after the pluripotent stem cells adhered to the wall, add sweat gland cell induction medium; then replace the culture sweat gland cell induction medium every day;
(3)待诱导后的多潜能干细胞生长至汇合率为70%,吸去培养基,用磷酸盐缓冲液(PBS)清洗,使用0.8mL 0.25%胰酶对细胞消化2分钟,使用含血清的培养基终止胰酶的作用,将消化下来的细胞吸入离心管中离心,1200转/分钟,离心5分钟。弃去上清,加入汗腺细胞诱导培养基,将细胞沉淀混匀,按1传4的比例接种细胞至新的培养皿中;(3) The induced pluripotent stem cells were grown to a confluence rate of 70%, the culture medium was aspirated, washed with phosphate buffered saline (PBS), and the cells were digested with 0.8mL 0.25% trypsin for 2 minutes. The medium stops the action of trypsin, and the digested cells are sucked into the centrifuge tube and centrifuged at 1200 rpm for 5 minutes. Discard the supernatant, add sweat gland cell induction medium, mix the cell pellet, and inoculate the cells into a new culture dish at a ratio of 1 to 4;
(4)重复步骤(3),诱导分化21天后得到汗腺样细胞,并对其进行汗腺指标的检测,利用汗腺细胞诱导培养基可以成功将多潜能干细胞诱导为汗腺样细胞。(4) Repeat step (3) to obtain sweat gland-like cells after 21 days of induction and differentiation, and detect sweat gland indicators on them. The pluripotent stem cells can be successfully induced into sweat gland-like cells by using the sweat gland cell induction medium.
附图7为体外培养的多潜能干细胞,多潜能干细胞诱导分化的汗腺样细胞以及人汗腺细胞在光学显微镜下的形态图。可以看出多潜能干细胞,细胞较小,呈克隆样生长,细胞核质比较高;由多潜能干细胞诱导分化得到的汗腺样细胞,细胞变大,成上皮细胞样,核质比变小;人汗腺细胞,细胞较大,具有明显的上皮细胞形态,呈铺路石状生长,细胞排列整齐。多潜能干细胞经过汗腺诱导培养基诱导分化后得到的汗腺样细胞在形态上接近体外培养的人汗腺细胞。Fig. 7 is a morphological diagram of pluripotent stem cells cultured in vitro, sweat gland-like cells induced and differentiated from pluripotent stem cells, and human sweat gland cells under an optical microscope. It can be seen that the pluripotent stem cells are small, grow in a clone-like manner, and have a high nuclear-cytoplasmic ratio; the sweat gland-like cells induced and differentiated from pluripotent stem cells, the cells become larger, epithelial-like, and the nuclear-cytoplasmic ratio becomes smaller; human sweat glands Cells, large cells, with obvious epithelial cell morphology, paving stone-like growth, cells arranged neatly. The sweat gland-like cells obtained after the differentiation of pluripotent stem cells by sweat gland induction medium are similar in morphology to human sweat gland cells cultured in vitro.
附图8为mRNA水平上检测诱导得到的汗腺样细胞的汗腺指标图。Realtime-PCR 结果显示,多潜能干细胞在诱导的过程中,逐渐表达汗腺细胞指标EDA、EDAR、K8 和CEA,且在分化的过程中逐渐接近汗腺细胞。多潜能干细胞(SG-iPS)作为阴性对照,人汗腺细胞(SG)作为阳性对照。Accompanying drawing 8 is the sweat gland indicator diagram of the induced sweat gland-like cells detected at the mRNA level. Realtime-PCR results showed that pluripotent stem cells gradually expressed sweat gland cell indicators EDA, EDAR, K8 and CEA during the induction process, and gradually approached sweat gland cells during the differentiation process. Pluripotent stem cells (SG-iPS) were used as a negative control, and human sweat gland cells (SG) were used as a positive control.
附图9为诱导得到的汗腺样细胞的分化比率图。经过21天的诱导,用流式细胞仪技术检测诱导后的细胞在汗腺细胞指标上的表达。经过分析,多潜能干细胞诱导后的汗腺样细胞表达EDA大约63%,EDAR大约65%, K8大约76%,CEA大约56%。多潜能干细胞可以被高产率的诱导分化为汗腺养细胞。Figure 9 is a diagram of the differentiation ratio of the induced sweat gland-like cells. After 21 days of induction, the expression of the induced cells on sweat gland cell indicators was detected by flow cytometry. After analysis, the sweat gland-like cells induced by pluripotent stem cells expressed about 63% of EDA, about 65% of EDAR, about 76% of K8, and about 56% of CEA. Pluripotent stem cells can be induced to differentiate into sweat gland trophoblasts at high yields.
附图10为透射电镜在细胞器水平上检测多潜能干细胞,多潜能干细胞诱导分化的汗腺样细胞以及人汗腺细胞的汗腺指标图。多潜能干细胞诱导后得到的汗腺样细胞在细胞器水平上接近人汗腺细胞,具体表现在诱导后的汗腺样细胞具有人汗腺细胞有的微绒毛(黑色箭头),而多潜能干细胞则没有微绒毛。Fig. 10 is a transmission electron microscope detection of pluripotent stem cells at the organelle level, sweat gland-like cells induced and differentiated from pluripotent stem cells, and sweat gland index diagrams of human sweat gland cells. The sweat gland-like cells induced by pluripotent stem cells are close to human sweat gland cells at the organelle level, specifically, the induced sweat gland-like cells have the microvilli (black arrows) that human sweat gland cells have, while the pluripotent stem cells do not have microvilli.
附图11为人汗腺组织,多潜能干细胞诱导分化的汗腺样细胞以及人汗腺细胞的汗腺样导管结构图,图中可见汗腺管状结构的横截面,能观察到汗腺管腔;多潜能干细胞诱导后得到的汗腺样细胞在胶中形成的汗腺管状结构,可见管状结构横截面以及管腔;人汗腺细胞在胶中形成的管状结构,可见管状结构横截面以及管腔。Accompanying drawing 11 is the structure diagram of human sweat gland tissue, sweat gland-like cells induced and differentiated by pluripotent stem cells, and sweat gland-like ducts of human sweat gland cells. In the figure, the cross-section of the sweat gland tubular structure can be seen, and the sweat gland lumen can be observed; after induction of pluripotent stem cells, The sweat gland tubular structure formed by human sweat gland-like cells in the gel, the tubular structure cross-section and lumen can be seen; the tubular structure formed by human sweat gland cells in the glue, the tubular structure cross-section and lumen can be seen.
附图12 为多潜能干细胞经诱导后得到的汗腺样细胞在胶中形成管腔的过程。汗腺样细胞在胶中增殖成团,中间的细胞逐渐凋亡,形成管腔。Figure 12 shows the process of forming tube lumens of sweat gland-like cells obtained from induced pluripotent stem cells in the gel. Sweat gland-like cells proliferated into clusters in the gel, and the cells in the middle gradually apoptotic to form a lumen.
综上所述,可以使用本发明的汗腺细胞诱导培养基成功诱导干细胞定向分化为汗腺样细胞,为大面积烧伤病人的救治提供足够数量的汗腺细胞,大大改善病人的生活质量。也为研究汗腺的分化发育提供的理论依据,具有潜在的临床应用前景。To sum up, the sweat gland cell induction medium of the present invention can be used to successfully induce the directional differentiation of stem cells into sweat gland-like cells, provide a sufficient number of sweat gland cells for the treatment of patients with extensive burns, and greatly improve the quality of life of patients. It also provides a theoretical basis for studying the differentiation and development of sweat glands, and has potential clinical application prospects.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410786562.3A CN104450606B (en) | 2014-12-18 | 2014-12-18 | Sweat gland cells inducing culture and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410786562.3A CN104450606B (en) | 2014-12-18 | 2014-12-18 | Sweat gland cells inducing culture and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104450606A CN104450606A (en) | 2015-03-25 |
CN104450606B true CN104450606B (en) | 2017-08-11 |
Family
ID=52897365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410786562.3A Active CN104450606B (en) | 2014-12-18 | 2014-12-18 | Sweat gland cells inducing culture and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104450606B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894053B (en) * | 2015-05-27 | 2019-02-26 | 苏州大学 | A method for forming sweat gland-like structures in glue |
CN107267444B (en) * | 2017-08-24 | 2020-06-12 | 广州润虹医药科技股份有限公司 | Culture medium and application thereof, and method for transforming mesenchymal stem cells into sweat gland-like cells |
CN107937333B (en) * | 2017-12-28 | 2020-09-15 | 广州润虹医药科技股份有限公司 | Culture medium and method for inducing fibroblast to differentiate sweat gland cells |
CN112725259B (en) * | 2021-01-07 | 2023-08-29 | 福州市皮肤病防治院 | Induction medium and induction method for differentiation of stem cells into sweat gland-like cells |
CN113583940A (en) * | 2021-08-31 | 2021-11-02 | 成都以邦医药科技有限公司 | Liver oval cell immortalized culture medium and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005087287A1 (en) * | 2004-03-05 | 2005-09-22 | University Of Florida Research Foundation Inc. | Novel tissue engineered scaffolds derived from copper capillary alginate gels |
CN101906401A (en) * | 2009-06-08 | 2010-12-08 | 中国人民解放军总医院第一附属医院 | A method for culturing and inducing adult bone marrow mesenchymal stem cells to transform into sweat gland cells under non-contact conditions |
-
2014
- 2014-12-18 CN CN201410786562.3A patent/CN104450606B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005087287A1 (en) * | 2004-03-05 | 2005-09-22 | University Of Florida Research Foundation Inc. | Novel tissue engineered scaffolds derived from copper capillary alginate gels |
CN101906401A (en) * | 2009-06-08 | 2010-12-08 | 中国人民解放军总医院第一附属医院 | A method for culturing and inducing adult bone marrow mesenchymal stem cells to transform into sweat gland cells under non-contact conditions |
Non-Patent Citations (1)
Title |
---|
体外诱导胚胎干细胞来源表皮干细胞向汗腺细胞分化的研究;罗文跃等;《赣南医学院学报》;20120430;第32卷(第2期);170-173 * |
Also Published As
Publication number | Publication date |
---|---|
CN104450606A (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3728750B2 (en) | Cultured skin and method for producing the same | |
CN104450606B (en) | Sweat gland cells inducing culture and its application | |
Takács et al. | Stem cells of the adult cornea: from cytometric markers to therapeutic applications | |
CN104419661B (en) | The preparation method of NSC | |
WO2016168950A1 (en) | Method for in vitro constructing salivary gland organoids and acinus-like | |
WO2010040302A1 (en) | Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof | |
Hamano et al. | Extracellular matrix from periodontal ligament cells could induce the differentiation of induced pluripotent stem cells to periodontal ligament stem cell-like cells | |
CN105331575B (en) | A kind of efficient amplification cultivating system of human vascular endothelial progenitor cells | |
CN114790446A (en) | A kind of cervical adenocarcinoma organoid culture medium and construction method thereof | |
Dai et al. | The Human Skin‐Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives | |
CN108324993B (en) | Stem cell complex for inducing hair regeneration, preparation method and application thereof | |
EP1904624B1 (en) | Method for culturing and proliferating hematopoietic stem cells and progenitor cells using human endometrial cells | |
CN103497892A (en) | Cell culture substrate, and preparation method and application thereof | |
JP4748222B2 (en) | Chondrocyte preparation method | |
CN105087475B (en) | A kind of method that cell culture fluid and its application and induction dental pulp stem cell break up to neural-like cells | |
JP2006187281A (en) | Precursor cell and cell aggregate each derived from human corneal endothelium cell, method for preparing those and method for transplanting precursor cell and cell aggregate | |
CN103893831B (en) | A kind of organotypic artificial skin, its preparation method and application | |
CN101906401A (en) | A method for culturing and inducing adult bone marrow mesenchymal stem cells to transform into sweat gland cells under non-contact conditions | |
CN103396982A (en) | Method for autocrine secretion of extracellular matrix by stem cells and induction of stem cells to become hepatocytes | |
CN106566810A (en) | Composition, inducer containing composition and induction method | |
CN105963795A (en) | Method for preparing tissue engineering epidermis based on collagen | |
CN107267444B (en) | Culture medium and application thereof, and method for transforming mesenchymal stem cells into sweat gland-like cells | |
CN116004529A (en) | Dermal papilla cell pellet, in vitro culture method, vesicle and application thereof | |
CN103103159A (en) | Cow mammary gland epithelial cell nutrient solution | |
CN107119011A (en) | A kind of culture medium and its amplification method for being used to expand human mesenchymal stem cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |